The prevention and treatment effect of Shenlingbaizhu Powder from the perspective of the mechanism of the occurrence of ovarian hyperstimulation syndrome

Guangdong Provincial Hospital of Chinese Medicine0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•? Patients who may develop OHSS and meet the TCM syndrome differentiation criteria of deficiency of spleen and kidney were evaluated during COH;
•? For ivF-ET patients aged 20-38 years, ovulation induction is suitable for fresh embryo transfer.
•? Patients who signed informed consent and agreed to participate in the clinical trial with good compliance.
•If the inclusion criteria above are not met, the patient cannot be included.

•? Those who have taken similar drug treatment recently and whose efficacy is difficult to judge, or have a history of drug or alcohol abuse.
•? Do not want to cooperate (such as not according to the provisions of the drug and affect the curative effect of qiao break) and mental illness, cognitive disorders.
•? Emergency measures must be taken if symptoms worsen.
•? Allergic constitution or allergic to a certain component of the drug used in the clinical trial.
•? Those who are participating in clinical trials of other drugs.
•? Failing to sign the informed consent.

发起方

Guangdong Provincial Hospital of Chinese Medicine